X
14Feb

CTS to Implement Donor HLA testing on the Stratec Gemini Instrument

0 Comments | | Return |

On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation. 

Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.

 

 

 

 

Related

Assay History List

We have now added a new section called the "Assay History List" to the "At A Gla...

Read More >

Reminder-MD Revised Headers on CTS forms

Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...

Read More >

CTS Tampa Implements New Laboratory Information System

On February 18, 2019, the New CTS Laboratory Information System has been successfully implemented in...

Read More >

Procedure for pouring off samples if shipments will be extremely delayed

As winter weather continues to move through parts of the US, we would like to remind you it may be n...

Read More >

Pooled Zika Testing and New CTS Website Functionality- November 29th Update

As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...

Read More >

Subscribe here to receive CTS updates!

Name